0 NASDAQ Companies - September 16, 2019Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)Read More
0 NYSE Companies - September 16, 2019Devon Energy Promotes David Harris to Executive Vice President, Exploration and ProductionRead More
0 NYSE Companies - September 16, 2019Par Pacific Holdings Reports Third Quarter 2019 Operational and Financial UpdatesRead More
0 NASDAQ Companies - September 16, 2019Regency Centers Invites You to Join Its Third Quarter 2019 Conference CallRead More
0 NASDAQ Companies - September 16, 2019Tonix Pharmaceuticals Announces Licensing Agreement with Columbia University for the Development of Recombinant Trefoil Family Factor 2 (rTFF2), or TNX-1700, for the Treatment of Gastric and Pancreatic CancersRead More
0 NASDAQ Companies - September 16, 2019Ocean Power Technologies Announces First Quarter Fiscal 2020 ResultsRead More
0 NASDAQ Companies - September 16, 2019Tracy Ting Appointed Chief Human Resources Officer for Encore Capital GroupRead More
0 NYSE Companies - September 16, 2019Sterling Bancorp Declares Quarterly Dividend on Preferred StockRead More
0 NASDAQ Companies - September 16, 201910x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesRead More
